Literature DB >> 31359197

Predicting venous thrombosis in patients undergoing elective splenectomy.

Peter Szasz1,2, Ali Ardestani3, Brent T Shoji4, David C Brooks4, Ali Tavakkoli4,5.   

Abstract

BACKGROUND: Venous thrombosis (VT) is an ongoing problem for patients undergoing elective splenectomy. There is limited data evaluating risk factors for VTs. An increase in platelet counts is commonly seen after splenectomy; however, there is a paucity of literature evaluating post-operative platelet counts as a risk factor for VTs in this patient cohort. The objective of this study was to determine the incidence of VT events and to use the platelet count as a predictor for VT development.
METHODS: A retrospective review was undertaken at Brigham Women's Hospital, evaluating elective splenectomy patients between 1997 and 2018. Descriptive statistics were utilized to determine the incidence of VTs. Receiver operator characteristic (ROC) curves were utilized to identify platelet counts that could predict VTs.
RESULTS: Five hundred and twenty splenectomies were included in the study of which 344 were completed in an open manner and 176 were done laparoscopically. The overall incidence of VT events was 6.7% (35/520), 6.1% (21/344) for open, and 8.0% (14/176) for laparoscopic approaches (p = 0.43). ROC curves demonstrated platelet counts to be a good predictor for the development of VTs with an area under the curve (AUC) of 0.77 (95% CI 0.69-0.86; p < 0.001) for all splenectomy patients, 0.70 (95% CI 0.59-0.81; p < 0.001) for those completed in an open manner, and 0.88 (95% CI 0.77-0.99; p < 0.001) for those done laparoscopically. The optimal platelet cutoff was found to be 545 for the overall splenectomy cohort, 457 for the open, and 659 for the laparoscopic cohorts. These platelet counts had a diagnostic accuracy that ranged from 61 to 86% and a negative predictive value (NPV) that ranged from 97 to 99%.
CONCLUSION: These results suggest platelet cutoffs that predict VTs. This information can be used to individualize prophylactic strategies.

Entities:  

Keywords:  Platelets; Splenectomy; Venous thrombosis

Mesh:

Year:  2019        PMID: 31359197     DOI: 10.1007/s00464-019-07007-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  25 in total

Review 1.  Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Lucas M Kimmig; Harold I Palevsky
Journal:  Ann Am Thorac Soc       Date:  2016-06

2.  Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens.

Authors:  Vadim P Koshenkov; Zoltán H Németh; Mitchel S Carter
Journal:  Am J Surg       Date:  2011-09-14       Impact factor: 2.565

3.  Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.

Authors: 
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

4.  High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan.

Authors:  Masataka Ikeda; Mitsugu Sekimoto; Shuji Takiguchi; Masaru Kubota; Masakazu Ikenaga; Hirofumi Yamamoto; Yoshiyuki Fujiwara; Masayuki Ohue; Takushi Yasuda; Hiroshi Imamura; Masayuki Tatsuta; Masahiko Yano; Hiroshi Furukawa; Morito Monden
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Incidence of portal vein thrombosis after laparoscopic splenectomy.

Authors:  William Harris; Michael Marcaccio
Journal:  Can J Surg       Date:  2005-10       Impact factor: 2.089

6.  Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy.

Authors:  Khaled M Musallam; Mohamed Khalife; Pierre M Sfeir; Walid Faraj; Bassem Safadi; George S Abi Saad; Firass Abiad; Ali Hallal; Melhim Bou Alwan; Flora Peyvandi; Faek R Jamali
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

7.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

8.  The postoperative splenic/portal vein thrombosis after splenectomy and its prevention--an unresolved issue.

Authors:  Maria-Theresa Krauth; Klaus Lechner; Edmund A M Neugebauer; Ingrid Pabinger
Journal:  Haematologica       Date:  2008-06-12       Impact factor: 9.941

Review 9.  On determining the most appropriate test cut-off value: the case of tests with continuous results.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh; Mahboobeh Yadollahie
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

10.  Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach.

Authors:  Ilker Unal
Journal:  Comput Math Methods Med       Date:  2017-05-31       Impact factor: 2.238

View more
  1 in total

1.  Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Authors:  Nichola Cooper; Ivy Altomare; Mark R Thomas; Phillip L R Nicolson; Steve P Watson; Vadim Markovtsov; Leslie K Todd; Esteban Masuda; James B Bussel
Journal:  Ther Adv Hematol       Date:  2021-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.